SYnAbs is a sponsor of the MabDesign Network

9 February 2022
New member

SYnAbsSYnAbs‘ mission is to generate innovative antibodies against poor immunogenic compounds (steroids, small molecules, carbohydrates, epigenetic modifications) and complex homologous epitopes (GPCR, ion channels, toxins, transporters, proteins from viral envelopes) thanks to unique technologies (conformational peptide immunization, syngeneic cell immunization, rat-LOU species, specific adjuvant). Anti-drug antibodies, surrogates, or therapeutics mAbs one-stop-shop solution from antigen to engineered antibody. To know more